Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: A Lipid Nanoparticle Suspension of Akt-1 Antisense Oligonucleotide
Date Designated: 09/20/2023
Orphan Designation: Treatment of Hepatocellular Carcinoma
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Zhejiang Haichang Biotech Co., Ltd.
Room 1109, West Zone Building 2, Lakeside Center, Xiasha Street, Qiantang New Area
Hangzhou, Zhejiang 310012
China

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-